Dr. Hess is a Clinician-Scientist at CPC Clinical Research who leads publication efforts and is involved in clinical trial design and event adjudication. She provides expertise in the design and implementation of clinical trials, related efficacy and safety endpoints, and their quality assurance. She also has experience in cardiovascular outcomes research and quality assessment. Her current research interests include percutaneous coronary intervention, acute coronary syndrome, antithrombotic therapies, and peripheral artery disease.
Dr. Hess is also an Assistant Professor of Medicine in the Department of Medicine, Division of Cardiology at the University of Colorado School of Medicine. She is a practicing interventional cardiologist and a member of the Vascular Medicine and Intervention section caring for patients with non-coronary vascular diseases. She is a Fellow of the American College of Cardiology, a Fellow of the Society for Cardiovascular Angiography and Interventions, and a member of the American Heart Association. She is involved in site-based clinical research at the University of Colorado and serves as a site PI for a randomized trial of antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
In addition to her experience with clinical research, Dr. Hess has a background in molecular and cellular biology. Her research has spanned the spectrum from molecular biology to outcomes and registry-based analyses to randomized clinical trials. This experience has given her unique insight into not only the strengths of each and how they complement one another but also the process of moving projects across the research spectrum and transitioning “from bench to bedside.”